Pharmalicensing.com: PR Newswire: OTC/Small Cap IRW http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us Pharmalicensing.com: PR Newswire: OTC/Small Cap IRW http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger NOVATO, California, September 30 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor") (OTC Bulletin Board: RPTP) and TorreyPines Therapeutics, Inc. ("TorreyPines") (Nasdaq: TPTX) announced... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3733 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3733 Wed, 30 Sep 2009 11:30:00 +0000 Cell Biosciences Signs Agreement to Acquire Alpha Innotech SANTA CLARA, California, September 8 /PRNewswire/ -- Cell Biosciences, Inc. and Alpha Innotech Corp. (OTC Bulletin Board: APNO) today announced that they have entered into a definitive... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3594 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3594 Tue, 08 Sep 2009 13:30:00 +0000 Helix BioPharma Announces CDN$13.5 Million Private Placement AURORA, Ontario, September 4 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: "HXBPF") today announced that it has accepted subscriptions for the purchase, by way of private placement,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3578 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3578 Fri, 04 Sep 2009 07:15:00 +0000 Helix BioPharma Announces the Appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its Board of Directors AURORA, Ontario, August 17 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: HBP / OTCQX: HXBPF) today announced the appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its board of directors.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3475 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3475 Mon, 17 Aug 2009 14:15:00 +0000 AACR 100th Annual Meeting Highlights Superior Ability of InNexus' DXL-Modified Anti-CD20 Antibody to Attach and Kill NHL With Safety Comparable to Approved Antibody Therapies in Preclinical Studies DENVER, April 20 /PRNewswire/ -- DXL625 monoclonal antibodies appear to be superior to commercial-stage antibodies in their ability to attach and deplete NHL in late stage pre-clinical studies,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2908 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2908 Mon, 20 Apr 2009 14:00:00 +0000 Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer NOVATO, California, April 13 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP) today announced the appointment of Patrice P. Rioux, M.D., Ph.D., as... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2876 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2876 Mon, 13 Apr 2009 11:30:00 +0000 Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business BALTIMORE, April 8 /PRNewswire/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2857 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2857 Wed, 08 Apr 2009 08:22:00 +0000 United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths IRVINE, California, February 18 /PRNewswire/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that in a newly... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2570 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2570 Wed, 18 Feb 2009 13:00:00 +0000 Hope for 14 Million Rosacea Sufferers: Pyratine-XR(TM) Study to be Presented at South Beach Symposium NAPA, California, February 12 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2547 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2547 Thu, 12 Feb 2009 14:25:00 +0000 Senetek PLC Launches Dedicated Pyratine-6(TM) Website NAPA, California, January 27 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2478 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2478 Tue, 27 Jan 2009 14:00:00 +0000 InNexus Completes Previously Announced Private Placement BRITISH COLUMBIA, Canada, January 27 /PRNewswire/ -- InNexus Biotechnology Inc. (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), announced today that it has completed a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2476 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2476 Tue, 27 Jan 2009 10:31:00 +0000 Senetek PLC Announces 2008 Annual General Meeting Voting Results NAPA, California, December 17 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2317 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2317 Wed, 17 Dec 2008 13:55:00 +0000 Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology NAPA, California, December 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2304 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2304 Mon, 15 Dec 2008 13:55:00 +0000 InNexus Biotechnology CEO Named Business Leader of the Year BRITISH COLUMBIA, Canada, November 17 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2145 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2145 Mon, 17 Nov 2008 13:59:00 +0000 Senetek PLC Reports Third Quarter 2008 Financial Results NAPA, California, November 14 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2135 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2135 Fri, 14 Nov 2008 21:30:00 +0000 Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program NOVATO, California, November 11 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced positive results in its Phase IIa study of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2104 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2104 Tue, 11 Nov 2008 15:00:00 +0000 CPC Launches New Web Site Highlighting Medical, Research and Technical Panel, MedClose(TM) VCS Animated Video SARASOTA, Florida, November 11 /PRNewswire/ -- CPC of America, Inc. (CPC) (OTC Bulletin Board: CPCF), today launched its new Web site, www.CPCMedDevices.com, to provide the medical and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2103 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2103 Tue, 11 Nov 2008 14:00:00 +0000 InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces US$1.25 Million Private Placement BRITISH COLUMBIA, Canada, November 7 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX Venture: IXS; http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2069 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2069 Fri, 07 Nov 2008 13:25:00 +0000 AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing PHILADELPHIA, October 31 /PRNewswire/ -- AVAX Technologies, Inc. (OTC Bulletin Board: AVXT) (the "Company") today announced that on October 24, 2008, it closed a bridge loan financing pursuant to a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2029 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2029 Fri, 31 Oct 2008 19:05:00 +0000 InNexus Biotechnology Receives Patent Grants in Europe BRITISH COLUMBIA, Canada, October 30 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2024 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2024 Thu, 30 Oct 2008 13:26:00 +0000 CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System SARASOTA, Florida, October 29 /PRNewswire/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF), a company focused on the development of therapeutic devices for use in endovascular procedures,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2013 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2013 Wed, 29 Oct 2008 13:00:00 +0000 Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences NOVATO, California, October 29 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced that senior management will present a corporate overview and clinical pipeline... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2007 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2007 Wed, 29 Oct 2008 06:14:00 +0000 InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum BRITISH COLUMBIA, Canada, October 28 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2004 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2004 Tue, 28 Oct 2008 20:39:00 +0000 CPC of America Announces Agreement with BC Tech for Manufacture of MedClose(TM) Vascular Closure System SARASOTA, Florida, October 24 /PRNewswire/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF), a company focused on developing therapeutic devices for use in endovascular procedures, announced today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1979 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1979 Fri, 24 Oct 2008 14:00:00 +0000 Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH) NOVATO, California, October 20 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the initiation of patient dosing in a Phase... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1935 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1935 Mon, 20 Oct 2008 11:30:00 +0000 Senetek Affirms Strong Financial Position NAPA, California, October 13 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1907 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1907 Mon, 13 Oct 2008 14:30:00 +0000 CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities SARASOTA, Florida, September 29 /PRNewswire/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF.OB) today announced that it had retained FTI Capital Advisors, LLC, the investment banking subsidiary of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1825 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1825 Mon, 29 Sep 2008 16:11:00 +0000 InNexus Biotechnology CEO to Present at BioContactQuebec 2008 BRITISH COLUMBIA, Canada, September 29 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1824 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1824 Mon, 29 Sep 2008 14:30:00 +0000 St. Joseph's Hospital and InNexus Biotechnology Enter Collaborative Partnership PHOENIX and BRITISH COLUMBIA, Canada, September 19 /PRNewswire/ -- St. Joseph's Hospital and Medical Center, part of Catholic Healthcare West, one of the largest healthcare systems in the West with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1765 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1765 Fri, 19 Sep 2008 14:20:00 +0000 InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies BRITISH COLUMBIA, Canada, September 16 /PRNewswire/ -- InNexus Biotechnology Inc. (TSX VENTURE: IXS; OTC Bulletin Board: IXSBF; http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1732 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1732 Tue, 16 Sep 2008 14:32:00 +0000 InNexus Biotechnology Strengthens Patent Team With New Leadership BRITISH COLUMBIA, Canada, September 9 /PRNewswire/ -- InNexus Biotechnology Inc., (TSX: IXS.V, OTC Bulletin Board: IXSBF, http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1687 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1687 Tue, 09 Sep 2008 14:25:00 +0000 InNexus Biotechnology CEO to Present at The Wall Street Analyst Forum in NYC BRITISH COLUMBIA, Canada, September 8 /PRNewswire/ -- InNexus Biotechnology Inc. (TSX: IXS.V; OTC Bulletin Board: IXSBF) (http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1669 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1669 Mon, 08 Sep 2008 14:15:00 +0000 Senetek Launches Pyratine-6(TM) NAPA, California, September 4 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1634 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1634 Thu, 04 Sep 2008 14:30:00 +0000 Senetek PLC Appoints Michael Rogers PR NAPA, California, September 3 /PRNewswire/ -- Senetek PLC, a life sciences company dedicated to the development of advanced anti-aging technologies, today announced the appointment of Michael Rogers... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1624 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1624 Wed, 03 Sep 2008 14:30:00 +0000 Senetek PLC Reports Second Quarter 2008 Financial Results NAPA, California, August 14 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1535 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1535 Thu, 14 Aug 2008 21:15:00 +0000 InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625 BRITISH COLUMBIA, Canada, August 7 /PRNewswire/ -- InNexus Biotechnology Inc., (TSX: IXS.V; OTC Bulletin Board: IXSBF) (http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1501 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1501 Thu, 07 Aug 2008 14:15:00 +0000 Global Med Technologies Announces Acquisition of eDonor(R): One of the Industry's Premier Technology Platforms for Donor Recruitment, Scheduling and Retention DENVER, August 1 /PRNewswire/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1478 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1478 Fri, 01 Aug 2008 14:00:00 +0000 Intellect Neurosciences, Inc. Obtains Pivotal European Patent Related To Monoclonal Antibody Passive Immunization Treatment Of Alzheimer's Disease NEW YORK, July 31 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) announced today it has obtained a European patent relating to the Company's ANTISENILIN(R) monoclonal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1471 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1471 Thu, 31 Jul 2008 11:10:00 +0000 GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine ATLANTA and NANTES, France, July 22 /PRNewswire/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1428 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1428 Tue, 22 Jul 2008 06:30:00 +0000 Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease NOVATO, California, July 16 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the execution of a collaboration agreement... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1400 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1400 Wed, 16 Jul 2008 11:30:00 +0000 Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board NOVATO, California, July 14 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced the appointments of Richard L. Franklin, M.D., Ph.D. to the Company's board of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1385 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1385 Mon, 14 Jul 2008 11:30:00 +0000 Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited NAPA, California, July 3 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1343 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1343 Thu, 03 Jul 2008 14:30:00 +0000 Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM) NAPA, California, July 1 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1331 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1331 Tue, 01 Jul 2008 14:30:00 +0000 Senetek PLC Resolves Dispute With Marketer of Pyratine-6(TM) on Most Favorable Terms NAPA, California, June 30 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1321 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1321 Mon, 30 Jun 2008 14:30:00 +0000 Raptor Pharmaceuticals Closes U.S.$10 Million Private Placement NOVATO, California, June 30 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced that it raised U.S.$10 million through a private placement of 20 million units... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1320 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1320 Mon, 30 Jun 2008 11:30:00 +0000 Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimer's Therapeutic Antibody NEW YORK, June 24 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) and MRC Technology (MRCT) announced today they have achieved an important milestone through their... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1276 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1276 Tue, 24 Jun 2008 11:00:00 +0000 Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008 NOVATO, California, June 23 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that Ted Daley, President of Raptor's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1262 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1262 Mon, 23 Jun 2008 11:30:00 +0000 Senetek PLC Announces Key Personnel Appointments NAPA, California, June 9 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1171 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1171 Mon, 09 Jun 2008 15:09:00 +0000 Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd. NEW YORK, May 19 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1029 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1029 Mon, 19 May 2008 12:45:00 +0000 Senetek PLC Reports First Quarter 2008 Financial Results NAPA, California, May 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1010 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1010 Thu, 15 May 2008 22:00:00 +0000 Starpharma Reports Positive VivaGel(R) Clinical Study Results MELBOURNE, Australia, May 12 /PRNewswire/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced positive results of a clinical trial that achieved all its objectives demonstrating... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/965 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/965 Mon, 12 May 2008 08:34:00 +0000 CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership LAS VEGAS, April 24 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. (OTC Bulletin Board: CVBTE) has entered into an agreement with Mr. Phillip Frey Jr. to form Cardio Derma Clinical Partners... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/856 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/856 Thu, 24 Apr 2008 13:00:00 +0000 Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM) NOVATO, California, April 21 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that its clinical development subsidiary,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/823 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/823 Mon, 21 Apr 2008 11:30:00 +0000 Access Pharmaceuticals Announces New Data on Angiolix(R) DALLAS, April 17 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced results from preclinical studies ongoing at the prestigious Imperial College London on Angiolix(R),... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/815 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/815 Thu, 17 Apr 2008 13:00:00 +0000 Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease NEW YORK, April 10 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), announced today that it has obtained a Notice of Allowance and completed the grant requirements to obtain... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/765 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/765 Thu, 10 Apr 2008 12:40:00 +0000 Global Med Technologies(R), Inc. and Cerner Announce Strategic Alliance DENVER, April 9 /PRNewswire/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that its Wyndgate... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/753 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/753 Wed, 09 Apr 2008 07:00:00 +0000 Global Med Technologies(R), Inc. Signs Purchase Agreement to Acquire Inlog, SA, a European Medical Software Firm DENVER, March 31 /PRNewswire/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/638 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/638 Mon, 31 Mar 2008 07:00:00 +0000